161 related articles for article (PubMed ID: 38256907)
1. The Bi-(AID-1-T) G-Quadruplex Has a Janus Effect on Primary and Recurrent Gliomas: Anti-Proliferation and Pro-Migration.
Pavlova S; Fab L; Savchenko E; Ryabova A; Ryzhova M; Revishchin A; Pronin I; Usachev D; Kopylov A; Pavlova G
Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256907
[TBL] [Abstract][Full Text] [Related]
2. Covalent Bi-Modular Parallel and Antiparallel G-Quadruplex DNA Nanocostructs Reduce Viability of Patient Glioma Primary Cell Cultures.
Legatova V; Samoylenkova N; Arutyunyan A; Tashlitsky V; Zavyalova E; Usachev D; Pavlova G; Kopylov A
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806042
[TBL] [Abstract][Full Text] [Related]
3. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
[TBL] [Abstract][Full Text] [Related]
4. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
5. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment.
Lefranc F; Rynkowski M; DeWitte O; Kiss R
Adv Tech Stand Neurosurg; 2009; 34():3-35. PubMed ID: 19368079
[TBL] [Abstract][Full Text] [Related]
6. FGFR1 Expression and Role in Migration in Low and High Grade Pediatric Gliomas.
Egbivwie N; Cockle JV; Humphries M; Ismail A; Esteves F; Taylor C; Karakoula K; Morton R; Warr T; Short SC; Brüning-Richardson A
Front Oncol; 2019; 9():103. PubMed ID: 30931252
[TBL] [Abstract][Full Text] [Related]
7. KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G; Grimaldi A; Chece G; Porzia A; Esposito V; Santoro A; Salvati M; Mainiero F; Ragozzino D; Di Angelantonio S; Wulff H; Catalano M; Limatola C
Oncotarget; 2016 May; 7(21):30781-96. PubMed ID: 27096953
[TBL] [Abstract][Full Text] [Related]
8. Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas.
Adamski V; Schmitt AD; Flüh C; Synowitz M; Hattermann K; Held-Feindt J
Oncol Res; 2017 Mar; 25(3):341-353. PubMed ID: 27641619
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of antitumor activity by using 5-ALA-mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model.
Suehiro S; Ohnishi T; Yamashita D; Kohno S; Inoue A; Nishikawa M; Ohue S; Tanaka J; Kunieda T
J Neurosurg; 2018 Dec; 129(6):1416-1428. PubMed ID: 29350596
[TBL] [Abstract][Full Text] [Related]
10. Actin Alpha 2, Smooth Muscle (ACTA2) Is Involved in the Migratory Potential of Malignant Gliomas, and Its Increased Expression at Recurrence Is a Significant Adverse Prognostic Factor.
Hoshimaru T; Nonoguchi N; Kosaka T; Furuse M; Kawabata S; Yagi R; Kurisu Y; Kashiwagi H; Kameda M; Takami T; Kataoka-Sasaki Y; Sasaki M; Honmou O; Hiramatsu R; Wanibuchi M
Brain Sci; 2023 Oct; 13(10):. PubMed ID: 37891844
[TBL] [Abstract][Full Text] [Related]
11. Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.
Thu MS; Najbauer J; Kendall SE; Harutyunyan I; Sangalang N; Gutova M; Metz MZ; Garcia E; Frank RT; Kim SU; Moats RA; Aboody KS
PLoS One; 2009 Sep; 4(9):e7218. PubMed ID: 19787043
[TBL] [Abstract][Full Text] [Related]
12. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
13. Increased Radiation-Associated T-Cell Infiltration in Recurrent IDH-Mutant Glioma.
Makarevic A; Rapp C; Dettling S; Reuss D; Jungk C; Abdollahi A; von Deimling A; Unterberg A; Herold-Mende C; Warta R
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096928
[TBL] [Abstract][Full Text] [Related]
14. The "go or grow" potential of gliomas is linked to the neuropeptide processing enzyme carboxypeptidase E and mediated by metabolic stress.
Höring E; Harter PN; Seznec J; Schittenhelm J; Bühring HJ; Bhattacharyya S; von Hattingen E; Zachskorn C; Mittelbronn M; Naumann U
Acta Neuropathol; 2012 Jul; 124(1):83-97. PubMed ID: 22249620
[TBL] [Abstract][Full Text] [Related]
15. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
Yamamoto Y; Ono Y; Aga F; Kawai N; Kudomi N; Nishiyama Y
J Nucl Med; 2012 Dec; 53(12):1911-5. PubMed ID: 23081994
[TBL] [Abstract][Full Text] [Related]
16. The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.
Senft C; Polacin M; Priester M; Seifert V; Kögel D; Weissenberger J
BMC Cancer; 2010 Sep; 10():491. PubMed ID: 20840775
[TBL] [Abstract][Full Text] [Related]
17. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
18. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
Hatakeyama T; Kawai N; Nishiyama Y; Yamamoto Y; Sasakawa Y; Ichikawa T; Tamiya T
Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2009-17. PubMed ID: 18542957
[TBL] [Abstract][Full Text] [Related]
19. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
Li DL; Xu YK; Wang QS; Wu HB; Li HS
Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
[TBL] [Abstract][Full Text] [Related]
20. Viability screen on pediatric low grade glioma cell lines unveils a novel anti-cancer drug of the steroid biosynthesis inhibitor family.
Ajeawung NF; Maltais R; Jones C; Poirier D; Kamnasaran D
Cancer Lett; 2013 Mar; 330(1):96-105. PubMed ID: 23201138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
